|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4184 | |
| A61P 35/00 |
| (11) | Patento numeris | 2131840 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08724338.2 |
| Europos patento paraiškos padavimo data | 2008-03-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-12-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/SG2008/000074 |
| Data | 2008-03-07 |
| (87) | Numeris | WO 2008/108741 |
| Data | 2008-09-12 |
| (30) | Numeris | Data | Šalis |
| 905293 P | 2007-03-07 | US | |
| 905299 P | 2007-03-07 | US |
| (72) |
GOH, Kay Lin, SG
KHNG, Hwee Hoon, SG
SABANAYAGAM, Vasantha, Malar, MY
SANGTHONGPITAQ, Kanda, SG
STUNKEL, Walter, SG
TAN, Yong Cheng, SG
WOOD, Jeanette Marjorie, SG
|
| (73) |
MEI Pharma, Inc.,
3611 Valley Centre Drive, Suite 500, San Diego, CA 92130,
US
|
| (54) | COMBINATION OF BENZIMIDAZOLE ANTI-CANCER AGENT AND A SECOND ANTI-CANCER AGENT |
| COMBINATION OF BENZIMIDAZOLE ANTI-CANCER AGENT AND A SECOND ANTI-CANCER AGENT |